MINNEAPOLIS, March 23 /PRNewswire-FirstCall/ -- Uroplasty, Inc. , a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,668,598 covering the stimulation method used in the Urgent(R) PC Neuromodulation System. The Urgent PC Neuromodulation System is a nonsurgical system for treatment of urinary urgency, urinary frequency and urinary urge incontinence, symptoms often associated with overactive bladder.
About the Urgent(R) PC Neuromodulation System
About Uroplasty, Inc.
We also offer Macroplastique(R) Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Macroplastique may be used for patients even if other incontinence treatments such as a sling procedure have failed. For complete information regarding Macroplastique, please refer to the Instructions for Use brochure available at the Uroplasty website at www.uroplasty.com.
This press release contains forward-looking statements, which reflect our best estimates regarding future events and financial performance. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our anticipated results. We discuss in detail the factors that may affect the achievement of our forward-looking statements in our Annual Report on Form 10-K filed with the SEC. In particular, our ability to continue to grow our Urgent PC sales is subject to a number risks, including the risk that third-party payors will provide or continue to provide coverage and reimbursement, or reimburse the providers an amount sufficient to cover their costs and expenses for Urgent PC treatments.
CONTACT: David Kaysen, President and CEO, or Medi Jiwani, Vice President,
CFO, and Treasurer, both of Uroplasty, Inc., +1-952-426-6140; or Investors,
Doug Sherk, +1-415-896-6820, or Media, Chris Gale, +1-646-201-5431, both of
EVC Group for Uroplasty, Inc.
Web site: http://www.uroplasty.com//